Metraipolis › archive › dc_86bddf7fe5ec

Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape — Europe PMC PMID:40802708

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40802708
DOI
10.1371/journal.pone.0328559
License (as archived)
solo-consultazione
Archived
2026-11-10T16:40:20.931Z
SHA-256 of the archived text
0b9a79836d33f4f49bb4ef6bb76b958cebcf8965c50c4c5d89c6db2c60f7a21c
Stable URL of this page
https://metraipolis.com/documento/dc_86bddf7fe5ec

How to cite

Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape — Europe PMC PMID:40802708 — Europe PMC (en), https://europepmc.org/article/MED/40802708 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86bddf7fe5ec (Metraipolis archive dc_86bddf7fe5ec, sha256 0b9a79836d33f4f49bb4ef6bb76b958cebcf8965c50c4c5d89c6db2c60f7a21c)
BibTeX
@misc{dc86bddf7fe5ec,
  title = {Gout management: Patent analytics and computational drug design explores URAT1 inhibitors landscape — Europe PMC PMID:40802708},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40802708},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86bddf7fe5ec; sha256 0b9a79836d33f4f49bb4ef6bb76b958cebcf8965c50c4c5d89c6db2c60f7a21c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40802708. Agents can read the archived copy with the MCP tool read_document.